The Covid effect has triggered some radical changes to the top 50 biopharma list, bringing a whole new group of players into the big league
Back on March 11 last year, the biopharma world was going into a global lockdown. The pandemic was officially hitting the US, and a broad …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
